Express Scripts’ Payer Clients On Board With Indication-Based Pricing, Exec Says
This article was originally published in The Pink Sheet Daily
Executive Summary
PBM provides an update on its indication-based pricing project for oncology drugs, claiming it has found a way around the Medicaid “best price” dilemma.